Drug Type Synthetic peptide |
Synonyms PN 881, PN881 |
Target |
Mechanism IL-17A inhibitors(Interleukin 17A inhibitors), IL-17F inhibitors(Interleukin-17F inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis, Psoriatic | Preclinical | AU | 21 Nov 2024 | |
Hidradenitis Suppurativa | Preclinical | AU | 21 Nov 2024 | |
Plaque psoriasis | Preclinical | AU | 21 Nov 2024 |